CS
IMNM icon

Credit Suisse’s Immunome IMNM Stock Holding History

Credit Suisse’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$838K Buy
+33,971
New +$689K ﹤0.01% 2374

Other funds holding IMNM

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Credit Suisse's IMNM Position: Q1 2024 in Review

Credit Suisse opened a new position in Immunome (IMNM) in Q1 2024: 33,971 shares worth $838K. The stake represents ﹤0.01% of the portfolio and ranks #2374 among its holdings.

104 funds tracked by Wall St. Rank hold IMNM as of Q1 2024.

  • Credit Suisse held 33,971 shares of Immunome worth $838K as of Q1 2024.
  • Immunome was a new Credit Suisse position in Q1 2024.
  • Immunome made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2374 holding.
  • 104 funds tracked by Wall St. Rank held Immunome as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.